12/04/2025
We’re proud to announce that Dr. Saad Ahmad has successfully completed the first ENCELTO™ procedure in Illinois, setting a new benchmark in retinal innovation!™ ENCELTO™is a, FDA-approved treatment to patients living with Macular Telangiectasia Type 2 (MacTel).
What is ENCELTO™?
• The first FDA-approved therapy for MacTel
• A first-in-class, encapsulated cell-based gene therapy
• A rice-sized implant that continuously releases rhCNTF to support retinal cell health and protect photoreceptors
For those affected by MacTel, ENCELTO™ offers a powerful new treatment option—and real hope for preserving vision.
At Kovach Eye Institute, we’re committed to advancing retinal care and delivering the most innovative therapies to the patients who need them most.